Young American Indians, ages 15-39, had cholesterol levels more than two times higher than the general U.S. population, according to new research published in the Journal of the American Heart Association , an open access, peer-reviewed journal of the American Heart Association. The researchers noted that previous research has estimated thatapproximately 25% of adolescents and approximately […]
In a significant development in pediatric healthcare, nirsevimab, a long-acting monoclonal antibody, has demonstrated robust real-world effectiveness in protecting infants against respiratory syncytial virus (RSV)-associated hospitalizations, according to an analysis by the New Vaccine Surveillance Network during the period of October 1, 2023, to February 29, 2024. The report was published in CDC Morbidity and […]
Prostate cancer is a common malignancy affecting men worldwide, and intermediate-risk prostate cancer (PCa) presents a challenging treatment scenario. MRI-guided focal therapy (FT) has emerged as a promising approach, allowing for targeted treatment while preserving healthy prostate tissue. However, long-term outcomes of this technique remain underexplored. A recent study aimed to evaluate the 2-year oncological […]
Recently published research paper discusses the effectiveness of single lung ventilation (SLV) using a double lumen tube (DLT) for providing surgical exposure in the thoracic cavity. It emphasizes the protective benefits of SLV for a healthy lung, highlighting the types of unhealthy lung fluids it protects from, such as blood, lavage fluid, malignant, or purulent […]
USA: Findings from phase 3 STARS trial demonstrate the potential for apraglutide to improve the standard of care for all adult patients with short bowel syndrome with intestinal failure (SBS-IF) dependent on parenteral support as the only GLP-2 with once-weekly administration, if approved. The study showed that treatment with apraglutide was associated with a reduction […]
The US Food and Drug Administration (FDA) has approved semaglutide (Wegovy) for reducing risk of cardiovascular death, heart attack, and stroke in adults with cardiovascular disease and either obesity or overweight. Wegovy should be used in addition to a reduced calorie diet and increased physical activity. Cardiovascular disease is a group of diseases of the […]
It is already known that Maternal diet during pregnancy is associated with child development. Nuts are nutrient-dense foods and provide fatty acids, vitamins, fibre, minerals and proteins. Pregnant women who consume nuts may potentially reduce the likelihood of their 5-year-old children experiencing peer problems, according to a study published in the Journal of Pediatric Gastroenterology […]
UK: A 14-year cohort study published in the Journal of Prosthetic Dentistry has found implant-supported prostheses to be effective and that oral rehabilitation under the specified conditions is stable. The researchers suggest that clinicians should consider this full-mouth rehabilitation with dental implants under general anesthesia (GA) as a viable option for cognitively and physically disabled […]
Mazdutide, a dual agonist drug was found to target weight reduction and additionally to manage blood glucose levels in individuals with overweight and obesity. The key highlights of this study was published in the recent edition of Frontiers in Endocrinology. Amidst the anticipation surrounding the efficacy of Mazdutide, the concerns regarding the scarcity of comprehensive evidence […]
South Korea: P2Y12 inhibitor monotherapy after 3-month dual antiplatelet therapy (DAPT) is not inferior to 12-month DAPT in patients with coronary artery disease undergoing PCI with the latest generation of drug-eluting stents, findings from SHARE Randomized Clinical Trial have shown. The findings were published online in JAMA Network Open on March 7, 2024. The randomized […]